391 related articles for article (PubMed ID: 25731642)
1. Complications of sclerotherapy for 75 head and neck venous malformations.
Castrén E; Aronniemi J; Klockars T; Pekkola J; Lappalainen K; Vuola P; Salminen P; Pitkäranta A
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1027-36. PubMed ID: 25731642
[TBL] [Abstract][Full Text] [Related]
2. The use of foam sclerotherapy for the treatment of head and neck vascular malformations.
Rehman KU; Sittampalam G; McCafferty I; Monaghan A
Br J Oral Maxillofac Surg; 2009 Dec; 47(8):631-2. PubMed ID: 19375203
[No Abstract] [Full Text] [Related]
3. Complications After Treatment of Head and Neck Venous Malformations With Sodium Tetradecyl Sulfate Foam.
Colletti G; Deganello A; Bardazzi A; Mattassi R; Dalmonte P; Gazzabin L; Stillo F
J Craniofac Surg; 2017 Jun; 28(4):e388-e392. PubMed ID: 28328612
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
Odeyinde SO; Kangesu L; Badran M
J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
[TBL] [Abstract][Full Text] [Related]
5. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
Chen AW; Liu SH; Huang YY; Wang T
Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
[TBL] [Abstract][Full Text] [Related]
7. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option.
Gregory S; Burrows PE; Ellinas H; Stadler M; Chun RH
Int J Pediatr Otorhinolaryngol; 2018 May; 108():30-34. PubMed ID: 29605361
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
Songsaeng D; Churojana A; Khumthong R; Mahiwan L
J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
Ali H; Saleh M; Mohammed W
Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
[TBL] [Abstract][Full Text] [Related]
15. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
16. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
[TBL] [Abstract][Full Text] [Related]
17. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm.
Guevara CJ; Gonzalez-Araiza G; Kim SK; Sheybani E; Darcy MD
Cardiovasc Intervent Radiol; 2016 May; 39(5):705-710. PubMed ID: 26678548
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Sclerotherapy for Treatment of Low-Flow Vascular Malformations of the Oropharyngeal Region.
Bourgouin P; Thomas-Chaussé F; Gilbert P; Giroux MF; Périgny S; Guertin L; Dubois J; Soulez G
J Vasc Interv Radiol; 2018 Jun; 29(6):809-815. PubMed ID: 29628299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]